<DOC>
	<DOC>NCT00729729</DOC>
	<brief_summary>A comparative bioavailability study of PCA slow release versus immediate release formulations, after a single dose to fasting healthy subjects.</brief_summary>
	<brief_title>Pharmacokinetic Study for PCA Derivate Formulations</brief_title>
	<detailed_description />
	<criteria>Subjects who have completed the informed consent process culminating with written informed consent by the subject. Males Age 1845 years Abstinence from alcohol for 1 week prior to the study Non smoking BMI &gt; 19 and &lt; 30 No history or evidence of significant cardiovascular, hepatic, renal, hematopoietic, gastrointestinal disease, endocrine, metabolic, psychiatric psychological disorders Normal physical examination Within +/ 10% of normal values in laboratory examinations Subjects who suffer from a current medical condition. Subjects who smoke. Subjects who drink &gt; 20 grams of alcohol per day. Subjects who take prescription medication. Subjects with an abnormality in screening blood tests Known sensitivity to any ingredients in the study drug</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Comparative</keyword>
	<keyword>bioavailability</keyword>
	<keyword>of PCA</keyword>
	<keyword>formulations</keyword>
</DOC>